José E Manautou Selected Research

José E Manautou Research Topics

Disease

7	Breast Neoplasms (Breast Cancer) 10/2019 - 02/2006
4	Drug-Related Side Effects and Adverse Reactions 01/2022 - 07/2015
4	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 10/2007
4	Necrosis 01/2016 - 01/2006
2	Obesity 01/2021 - 01/2008
2	Neoplasms (Cancer) 01/2016 - 06/2007
2	Acute Kidney Injury (Acute Renal Failure) 05/2014 - 09/2008
2	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 10/2007 - 03/2006
2	Disease Progression 06/2007 - 03/2006
2	Cholestasis 01/2006 - 01/2006
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2022
1	Rare Diseases (Rare Disease) 01/2021
1	Hypercholesterolemia 01/2021
1	Glucose Intolerance 01/2021
1	Gliosis 12/2019
1	Hepatic Encephalopathy 12/2019
1	Fatty Liver 04/2016
1	Inflammation (Inflammations) 04/2016
1	Non-alcoholic Fatty Liver Disease 04/2016
1	Pain (Aches) 07/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2014
1	Type 2 Diabetes Mellitus (MODY) 01/2008
1	Liver Failure 10/2007

Drug/Important Bio-Agent (IBA)

9	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022 - 01/2006
8	Proteins (Proteins, Gene)FDA Link 10/2019 - 02/2006
7	Multidrug Resistance-Associated ProteinsIBA 01/2021 - 02/2006
6	Messenger RNA (mRNA)IBA 04/2016 - 05/2006
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2008
3	quinone (benzoquinone)IBA 04/2016 - 01/2006
3	Peptides (Polypeptides)IBA 09/2008 - 02/2006
3	AnionsIBA 09/2008 - 01/2006
2	Biological ProductsIBA 01/2022 - 07/2015
2	Diclofenac (SR 38)FDA LinkGeneric 10/2019 - 07/2015
2	Cisplatin (Platino)FDA LinkGeneric 05/2014 - 09/2008
2	CationsIBA 09/2008 - 01/2008
2	Taurocholic Acid (Sodium Taurocholate)IBA 01/2008 - 02/2006
2	EnzymesIBA 01/2008 - 03/2006
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2008 - 10/2007
2	NAD (NADH)IBA 03/2006 - 01/2006
2	Oxidoreductases (Dehydrogenase)IBA 03/2006 - 01/2006
1	Antisense OligonucleotidesIBA 01/2022
1	casimersenIBA 01/2022
1	ALN-PCSIBA 01/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	LeptinIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	TeaIBA 04/2016
1	NADP (NADPH)IBA 04/2016
1	Malondialdehyde (Propanedial)IBA 04/2016
1	LipidsIBA 04/2016
1	PolymersIBA 01/2016
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2016
1	1- O- (2- ((2',6'- dichlorophenyl)amino)phenylacetyl)glucopyranuronic acidIBA 07/2015
1	Galectin 3 (LGALS3)IBA 01/2014
1	IronIBA 09/2008
1	ferric nitrilotriacetateIBA 09/2008
1	Subfamily B ATP Binding Cassette TransporterIBA 09/2008
1	Carrier Proteins (Binding Protein)IBA 09/2008
1	XenobioticsIBA 09/2008
1	BuffersIBA 01/2008
1	Citric Acid (Citrate)FDA LinkGeneric 01/2008
1	dimethylethylsilylimidazoleIBA 01/2008
1	Streptozocin (Streptozotocin)FDA Link 01/2008
1	DNA (Deoxyribonucleic Acid)IBA 10/2007
1	AntioxidantsIBA 06/2007
1	Benzo(a)pyreneIBA 06/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2007
1	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2006
1	Coloring Agents (Dyes)IBA 01/2006

Therapy/Procedure

2	Therapeutics 01/2021 - 06/2007